Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | NanoString Technologies, Inc. NSTGQ |
Polar Capital Holdings Plc | 3,778,731 8.100% |
3,778,731 (New Position) |
Filing History |
| 2023-02-14 3:59 pm Sale |
2022-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Polar Capital Holdings Plc | 2,071,242 2.300% |
-2,928,758 (-58.58%) |
Filing History |
| 2022-02-14 10:58 am Sale |
2021-12-31 | 13G | BELLUS Health Inc. BLU |
Polar Capital Holdings Plc | 2,500,000 2.400% |
-1,000,000 (-28.57%) |
Filing History |
| 2022-02-14 10:47 am Purchase |
2021-12-31 | 13G | Summit Therapeutics Inc. SMMT |
Polar Capital Holdings Plc | 6,295,713 6.400% |
495,713 (+8.55%) |
Filing History |
| 2022-02-14 10:46 am Unchanged |
2021-12-31 | 13G | Quotient Limited QTNT |
Polar Capital Holdings Plc | 231,291 9.040% |
0 (Unchanged) |
Filing History |
| 2022-02-14 10:46 am Sale |
2021-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD |
Polar Capital Holdings Plc | 0 0.000% |
-2,568,385 (Position Closed) |
Filing History |
| 2022-02-14 10:41 am Purchase |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Polar Capital Holdings Plc | 5,000,000 5.600% |
5,000,000 (New Position) |
Filing History |
| 2022-02-14 10:40 am Sale |
2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
Polar Capital Holdings Plc | 2,794,673 4.800% |
-233,032 (-7.70%) |
Filing History |
| 2021-02-16 07:32 am Purchase |
2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
Polar Capital Holdings Plc | 3,027,705 5.200% |
3,027,705 (New Position) |
Filing History |
| 2021-02-16 07:32 am Purchase |
2020-12-31 | 13G | BELLUS Health Inc. BLU |
Polar Capital Holdings Plc | 3,500,000 4.470% |
3,500,000 (New Position) |
Filing History |
| 2021-02-16 07:32 am Purchase |
2020-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD |
Polar Capital Holdings Plc | 2,568,385 9.890% |
2,568,385 (New Position) |
Filing History |
| 2021-02-16 07:32 am Purchase |
2020-12-31 | 13G | Quotient Limited QTNT |
Polar Capital Holdings Plc | 231,291 9.160% |
231,291 (New Position) |
Filing History |
| 2021-02-16 07:32 am Purchase |
2020-12-31 | 13G | Summit Therapeutics Inc. SMMT |
Polar Capital Holdings Plc | 5,800,000 7.050% |
5,800,000 (New Position) |
Filing History |